(RYTM) Rhythm Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Rhythm Pharmaceuticals | (RYTM) share price targets
Complete technical analysis of Rhythm Pharmaceuticals (RYTM) by charts plus indicators, forecast predictions and share price targets for Rhythm Pharmaceuticals (RYTM)
Rhythm Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-18 View latest technical analysis
10 day averaged volume of Rhythm Pharmaceuticals is 544700
Date | Daily Closing Price | Open | High | Low | Volume |
18 Tue Jun 2024 | 41.39 | 41.35 | 41.48 | 40.09 | 0.653 times |
18 Tue Jun 2024 | 41.39 | 41.35 | 41.48 | 40.09 | 0.653 times |
17 Mon Jun 2024 | 41.16 | 42.36 | 42.38 | 40.48 | 0.928 times |
14 Fri Jun 2024 | 42.77 | 44.66 | 45.92 | 42.30 | 1.374 times |
13 Thu Jun 2024 | 44.37 | 42.22 | 44.62 | 41.55 | 1.223 times |
12 Wed Jun 2024 | 42.27 | 41.43 | 42.88 | 40.91 | 1.168 times |
11 Tue Jun 2024 | 40.12 | 40.70 | 41.30 | 39.58 | 0.933 times |
10 Mon Jun 2024 | 41.01 | 39.31 | 41.05 | 38.90 | 0.739 times |
07 Fri Jun 2024 | 39.97 | 39.20 | 40.50 | 38.85 | 0.856 times |
06 Thu Jun 2024 | 39.68 | 39.79 | 40.12 | 39.01 | 0.81 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 41.8 as stoploss in an intra day sell trade for a target of 39.38. However, stock will show a bullish move above 41.8.
Share price targets for Rhythm Pharmaceuticals (RYTM)
Target Type | Value |
Downside Target | 35.17 |
Downside Target | 36.27 |
Downside Target | 38.90 |
Downside Target | 40.09 |
Upside Target | 41.48 |
Upside Target | 42.38 |
Upside Target | 42.65 |
Upside Target | 43.68 |
Upside Target | 44.37 |
Upside Target | 45.49 |
Upside Target | 45.92 |
Upside Target | 52.57 |
Intraday share price targets for Rhythm Pharmaceuticals (RYTM)
Target Type | Value |
Downside Intraday Target | 40.49 |
Downside Intraday Target | 39.6 |
Upside Intraday Target | 41.88 |
Upside Intraday Target | 42.38 |
Downside Intraday Target | 40.99 |
Weekly technical analysis of Rhythm Pharmaceuticals (RYTM)
Date | Weekly Closing Price | Open | High | Low | Volume |
18 Tue Jun 2024 | 41.39 | 41.35 | 41.48 | 40.09 | 0.413 times |
18 Tue Jun 2024 | 41.39 | 42.36 | 42.38 | 40.09 | 0.291 times |
14 Fri Jun 2024 | 42.77 | 39.31 | 45.92 | 38.90 | 1.081 times |
07 Fri Jun 2024 | 39.97 | 36.40 | 40.50 | 36.27 | 1.391 times |
31 Fri May 2024 | 35.68 | 37.12 | 37.55 | 35.17 | 1.145 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Rhythm Pharmaceuticals (RYTM)
Date | Monthly Closing Price | Open | High | Low | Volume |
18 Tue Jun 2024 | 41.39 | 36.40 | 45.92 | 36.27 | 0.561 times |
31 Fri May 2024 | 35.68 | 39.77 | 44.37 | 35.17 | 1.153 times |
30 Tue Apr 2024 | 39.76 | 42.30 | 43.68 | 36.92 | 0.887 times |
28 Thu Mar 2024 | 43.33 | 42.67 | 45.49 | 37.66 | 0.956 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Rhythm Pharmaceuticals (RYTM)
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Rhythm Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Rhythm Pharmaceuticals in short term and the buy signal is strong.
Rhythm Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Rhythm Pharmaceuticals in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Rhythm Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 41.64 and Rhythm Pharmaceuticals (RYTM) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Rhythm Pharmaceuticals (RYTM) stock. Volume based technical analysis of Rhythm Pharmaceuticals (RYTM) stock is negative.
Rhythm Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Rhythm Pharmaceuticals ( (RYTM) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Rhythm Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Rhythm Pharmaceuticals in short term and the buy signal is strong.
Rhythm Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Rhythm Pharmaceuticals in short term
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Rhythm Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 41.64 and Rhythm Pharmaceuticals (RYTM) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Rhythm Pharmaceuticals (RYTM) stock. Volume based technical analysis of Rhythm Pharmaceuticals (RYTM) stock is negative.
Rhythm Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.